Pepti — China peptide manufacturer

Compliance position

We say no when no is the right answer.

Pepti serves qualified B2B and research buyers, OEM brand owners and research labs. We do not sell to consumers, and we provide no medical advice. The GLP-1 family is supplied as research peptides worldwide; buyers confirm local regulatory compliance.

Buyer policy

Two clear lines for who we sell to.

Inquiries from these contexts get a fast, structured reply. Everything else gets a polite redirect.

Allowed buyer contexts

  • Qualified B2B research buyers
  • Research organizations
  • Qualified distributors with a research-use procurement context
  • Research labs (university, hospital, private)
  • Private-label and OEM brand owners
  • Distributors and private-label brands for the GLP-1 family (research use)

Not supplied

  • Consumer-direct medical advice, treatment claims, dosing or administration guidance
  • Consumer, therapeutic or clinical-use supply requests
  • Any buyer who cannot identify a qualified B2B or research context
  • Any end use restricted by a buyer's local regulations

Research-use boundary

Regulatory responsibility stays with the buyer.

B2B research supplyPepti supplies research-use peptide materials, batch documents and private-label packaging support for qualified organizations.
No medical positioningPepti does not provide dosing, administration guidance, treatment claims, diagnosis support or consumer-facing medical instructions.
Local complianceBuyers confirm import rules, registration requirements, labeling obligations and permitted end use in their destination market before ordering.
GLP-1 family (research)Research and private-label brand evaluation, supplied worldwide as research peptides. Buyer context is confirmed before quoting.

What we do not provide

Hard limits, written plainly.

No medical advice

No diagnosis, treatment claim, dosing, administration guidance or therapeutic implication. Pepti gives no medical advice; qualified buyers remain responsible for lawful research handling and local compliance.

No consumer sales

Pepti is B2B and research only. We do not sell to consumers and do not market to consumers.

No restricted supply

No supply to use cases restricted by the FDA's 2026 regulatory bulk-substance framework proposal or other applicable regulatory frameworks.

Read the GLP-1 update

A clearer view of where US GLP-1 supply is heading.

Research-use boundaries, buyer qualification, batch documentation and what they mean for qualified B2B research buyers and brand owners.

Read the GLP-1 2026 update →
WhatsApp us